Training activity information
Details
Perform HDR post source change quality assurance
Type
Developmental training activity (DTA)
Evidence requirements
Evidence the activity has been undertaken by the trainee.
Reflection on the activity at one or more time points after the event including learning from the activity and/or areas of the trainees practice for development.
An action plan to implement learning and/or to address skills or knowledge gaps identified.
Considerations
- Guidance and legislation
- Code of practice and dosimetry chain
- Security considerations for radioactive source
Reflective practice guidance
The guidance below is provided to support reflection at different time points, providing you with questions to aid you to reflect for this training activity. They are provided for guidance and should not be considered as a mandatory checklist. Trainees should not be expected to provide answers to each of the guidance questions listed.
Before action
- What are the key quality assurance checks that need to be performed after an HDR source change?
- What are the regulatory requirements associated with this process?
- How does this activity contribute to safe, patient-centred treatments?
- What prior knowledge of HDR equipment and QA procedures is essential?
- What specific steps will you take to prepare for performing these checks accurately?
- What potential issues might arise during the QA process, and how could you address them?
- What radiation safety procedures should you follow?
In action
- Are you following the correct procedures, and do they feel intuitive?
- What decisions are you making about the order of checks or the interpretation of results?
- Are you noticing any unexpected readings or equipment behaviours?
- Are you confident that you are adhering to safety protocols and regulatory requirements?
- If you are encountering a problem, what alternative troubleshooting steps are you considering?
- Do you need to seek any immediate advice or support?
On action
- What were the main steps involved in the QA process? Were there any particular measurements or checks that stood out?
- Did you encounter any results outside of tolerance? What did you learn from the process of identifying and addressing these? Did the procedure feel more or less intuitive than expected? What contributed to this? How did this activity reinforce your understanding of safety protocols and regulatory requirements related to radioactive sources? What did you learn about the importance of thorough QA in maintaining the accuracy and safety of HDR brachytherapy?
- Are there any specific aspects of the QA procedure you need to review or practice further? How will you ensure you remain vigilant in adhering to safety protocols in future source changes? What steps will you take to further develop your understanding of the underlying physics and tolerances involved in HDR QA?
Beyond action
- Have you revisited your reflections on performing HDR post source change quality assurance? How does your understanding of the importance of this activity compare now to when you first performed it?
- Consider other quality assurance activities you have undertaken. How has the experience of performing HDR post source change quality assurance informed your approach to these other activities? What observable behaviours or practices have you assimilated into your routine QA work?
- How have the skills and knowledge gained from this training activity contributed to your ability to ensure the safe and effective delivery of HDR brachytherapy in your practice since?
Relevant learning outcomes
| # | Outcome |
|---|---|
| # 1 |
Outcome
Perform required measurements to establish brachytherapy and specialist treatment machines are suitable for clinical use, interpret results and instigate corrective action where required. |
| # 4 |
Outcome
Interpret and apply the regulatory framework on the safe use of radioactive sources in a clinical environment. |
| # 8 |
Outcome
Practice effectively as part of a multidisciplinary team to provide safe, patient centred radiotherapy treatments. |